These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Neuropathic pain: Review of mechanisms and pharmacologic management. Orza F; Boswell MV; Rosenberg SK NeuroRehabilitation; 2000; 14(1):15-23. PubMed ID: 11455064 [TBL] [Abstract][Full Text] [Related]
24. Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer. Bates N; Bello JK; Osazuwa-Peters N; Sullivan MD; Scherrer JF Curr Treat Options Oncol; 2022 Mar; 23(3):348-358. PubMed ID: 35254595 [TBL] [Abstract][Full Text] [Related]
25. Demographics, assessment and management of pain in the elderly. Davis MP; Srivastava M Drugs Aging; 2003; 20(1):23-57. PubMed ID: 12513114 [TBL] [Abstract][Full Text] [Related]
26. Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study. Matsuoka H; Ishiki H; Iwase S; Koyama A; Kawaguchi T; Kizawa Y; Morita T; Matsuda Y; Miyaji T; Ariyoshi K; Yamaguchi T BMJ Open; 2017 Aug; 7(8):e017280. PubMed ID: 28851798 [TBL] [Abstract][Full Text] [Related]
29. [Neuropathic pain due to malignancy: mechanisms, clinical manifestations and therapy]. Pjević M; Patarica-Huber E; Radovanović D; Vicković S Med Pregl; 2004; 57(1-2):33-40. PubMed ID: 15327188 [TBL] [Abstract][Full Text] [Related]
30. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison. Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618 [TBL] [Abstract][Full Text] [Related]
32. [DRUG THERAPY OF NEUROPATHIC PAIN BASED ON THE LATEST RECOMMENDATIONS]. Kiss G Ideggyogy Sz; 2015 Mar; 68(3-4):93-8. PubMed ID: 26434196 [TBL] [Abstract][Full Text] [Related]
33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
34. Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study. Zhao Y; Liu J; Zhao Y; Thethi T; Fonseca V; Shi L Pain Pract; 2012 Jun; 12(5):366-73. PubMed ID: 21951753 [TBL] [Abstract][Full Text] [Related]
35. Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol. Matsuoka H; Clark K; Fazekas B; Oyamada S; Brown L; Ishiki H; Matsuda Y; Hasuo H; Ariyoshi K; Lee J; Le B; Allcroft P; Kochovska S; Fujiwara N; Miyaji T; Lovell M; Agar M; Yamaguchi T; Satomi E; Iwase S; Phillips J; Koyama A; Currow DC BMJ Open; 2022 Feb; 12(2):e050182. PubMed ID: 35131817 [TBL] [Abstract][Full Text] [Related]
36. Impact of a clinical pharmacy consult service on guideline adherence and management of gabapentin for neuropathic pain. Winterbottom LM; Fong AM; Benkstein KL; Liang B; Snodgrass LS; Parks-Huitron H J Manag Care Pharm; 2006; 12(1):61-9. PubMed ID: 16420109 [TBL] [Abstract][Full Text] [Related]